PA-8 is a small molecule receptor antagonist for PACAP Type I (PAC1) that is selective, effective, and orally active. PA-8 inhibits PacAP-induced CREB phosphorylation at PAC1- receptors, but does not inhibit VPAC1- or vpac2 receptors.

Labotest-bb lt00007814 ((1E)-1-(2-hydroxy-5-methylphenyl)-1-dodecanone oxime) is a compound that can be used in biological research.

Moguisteine is a novel peripheral non-narcotic antitussive drug.